secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 76264 grounded facts newest August 31, 2026, 5:22 PM ET RSS · JSON

Showing 3751–3800 of 18625

Appointed

Terry Kohler

Chief Financial Officer
OptiNose, Inc.
Effective
2024-10-07
Filed
October 8, 2024, 7:59 PM ET
On October 7, 2024, OptiNose, Inc. (the “Company”) appointed Terry Kohler as the Company’s Chief Financial Officer.
Appointed

Khalid Nasser A.S. Al-Thani

Chairman and CEO
HIRU · HIRU Corp
Filed
October 8, 2024, 7:59 PM ET
Khalid Nasser A.S. Al-Thani on a position as Chairman and CEO
Appointed

James Peter Thorp

CFO
HIRU · HIRU Corp
Filed
October 8, 2024, 7:59 PM ET
James Peter Thorp will assume the position of CFO
Appointed

Brian J. Harris

Chief Financial Officer
ASTE · ASTEC INDUSTRIES INC
Effective
2024-10-07
Filed
October 7, 2024, 7:59 PM ET
Brian J. Harris has been appointed as Chief Financial Officer of the Company, effective October 7, 2024
Departed

Ann Beemish

Chief Financial Officer
MDIA · Mediaco Holding Inc.
Filed
October 7, 2024, 7:59 PM ET
On October 1, 2024, the Company and Ms. Beemish entered into a Separation and General Release Agreement, dated October 1, 2024 (the “Separation Agreement”), pursuant to which Ms. Beemish will receive, upon execution of a customary release and the completion and termination of the Consulting Agreement (as discussed below), payment of $170,238, payable in equal monthly installments over a six-month period.
Role change

Umesh Mahajan

Co-Chief Investment Officer, Chief Financial Officer and Secretary
LIEN · Chicago Atlantic BDC, Inc.
Effective
2024-10-01
Filed
October 7, 2024, 7:59 PM ET
Umesh Mahajan has become Co-Chief Investment Officer of the Company in addition to remaining Chief Financial Officer and Secretary of the Company
Appointed

Andreas Bodmeier

Chief Executive Officer
LIEN · Chicago Atlantic BDC, Inc.
Effective
2024-10-01
Filed
October 7, 2024, 7:59 PM ET
Andreas Bodmeier has replaced Scott Gordon as Chief Executive Officer of the Company
Departed (interim)

Tom Reilly

Executive Vice President, Chief Financial Officer and Head of Global HR & Finance
AMRN · AMARIN CORP PLCUK
Effective
2024-10-23
Successor
Peter Fishman
Filed
October 7, 2024, 7:59 PM ET
On October 1, 2024, Tom Reilly notified Amarin Corporation plc (the “Company”) of his decision to voluntarily resign as Executive Vice President, Chief Financial Officer and Head of Global HR & Finance, effective October 23, 2024, to pursue another opportunity.
Appointed (interim)

Peter Fishman

Vice President, Global Controller (assuming principal financial officer and principal accounting officer duties)
AMRN · AMARIN CORP PLCUK
Effective
2024-10-23
Filed
October 7, 2024, 7:59 PM ET
In the interim, the Company’s Vice President, Global Controller, Peter Fishman, will assume the duties as principal financial officer and principal accounting officer of the Company, reporting to the CEO, Aaron Berg, until the Company appoints a permanent replacement.
Appointed

Bryan Schumaker

Executive Vice President, Chief Financial Officer and Principal Accounting Officer
BHE · BENCHMARK ELECTRONICS INC
Effective
2024-10-08
Filed
October 7, 2024, 7:59 PM ET
On October 7, 2024, Benchmark Electronics, Inc. (the “Company”) announced the appointment of Bryan Schumaker, 48, as Executive Vice President (EVP), Chief Financial Officer (CFO) and Principle Accounting Officer.
Departed

Dwight Gorham

Chief Executive Officer
IntelGenx Technologies Corp.
Effective
2024-10-02
Filed
October 7, 2024, 7:59 PM ET
O n October 2, 2024, Dwight Gorham, Chief Executive Officer of the Company, Andre Godin, Chief Financial Officer of the Company, and Ingrid Zerbe, Corporate Secretary of the Company, resigned from their respective positions.
Departed

Andre Godin

Chief Financial Officer
IntelGenx Technologies Corp.
Effective
2024-10-02
Filed
October 7, 2024, 7:59 PM ET
O n October 2, 2024, Dwight Gorham, Chief Executive Officer of the Company, Andre Godin, Chief Financial Officer of the Company, and Ingrid Zerbe, Corporate Secretary of the Company, resigned from their respective positions.
Appointed (interim)

Ali Manav

Acting Chief Executive Officer
BASA · BASANITE, INC.
Effective
2024-10-02
Filed
October 7, 2024, 7:59 PM ET
On October 2, 2024, Ali Manav agreed to become the Acting Chief Executive Officer of Basanite, Inc. (the “Company”) through June 30, 2025.
Departed

Howard Lorber

Chief Executive Officer
VECTOR GROUP LTD
Effective
2024-10-07
Filed
October 7, 2024, 7:59 PM ET
The Company has determined that it will terminate the employment of Messrs. Lorber, Lampen, Kirkland and Bell, with such terminations becoming effective on the Closing Date but following the Closing.
Departed

J. Bryant Kirkland III

Senior Vice President, Chief Financial Officer and Treasurer
VECTOR GROUP LTD
Effective
2024-10-07
Filed
October 7, 2024, 7:59 PM ET
The Company has determined that it will terminate the employment of Messrs. Lorber, Lampen, Kirkland and Bell, with such terminations becoming effective on the Closing Date but following the Closing.
Appointed

Erika Jones

principal financial officer
BDTX · Black Diamond Therapeutics, Inc.
Effective
2024-10-07
Filed
October 7, 2024, 7:59 PM ET
Erika Jones, the Company’s Senior Vice President, Finance and Corporate Controller, and principal accounting officer, was appointed as principal financial officer of the Company.
Departed

Fang Ni

Chief Business Officer, Chief Financial Officer and principal financial officer
BDTX · Black Diamond Therapeutics, Inc.
Effective
2024-10-07
Successor
Erika Jones
Filed
October 7, 2024, 7:59 PM ET
On October 7, 2024, Black Diamond Therapeutics, Inc. (the “Company”) terminated Fang Ni, Pharm. D. without Cause (as such term is defined in his employment agreement with the Company, which was filed as Exhibit 10.12 to the Company’s Annual Report on Form 10-K filed on March 9, 2023 (the “Employment Agreement”)) as Chief Business Officer, Chief Financial Officer and principal financial officer of the Company, in each case, effective as of October 7, 2024
Appointed

Steven Bailey

Chief Financial Officer
MTCH · Match Group, Inc.
Effective
2025-03-01
Filed
October 7, 2024, 7:59 PM ET
the Board of Directors (the “Board”) of Match Group, Inc. (the “Company”) appointed Steven Bailey as the Company’s Chief Financial Officer, effective March 1, 2025
Appointed

Philippe Sauvage

Chief Financial Officer
NUVB · Nuvation Bio Inc.
Effective
2024-10-07
Filed
October 7, 2024, 7:59 PM ET
Effective October 7, 2024 (the “Appointment Date”), the Board of Nuvation Bio Inc. (the “Company”) appointed Philippe Sauvage as the Company’s Chief Financial Officer and Principal Financial Officer.
Appointed

Brian Krzanich

President and Chief Executive Officer
CRNC · Cerence Inc.
Effective
2024-10-07
Filed
October 7, 2024, 7:59 PM ET
On October 6, 2024, the Board of Directors (the “Board”) of the Company appointed Brian Krzanich as President and Chief Executive Officer (and “principal executive officer”) of the Company, effective October 7, 2024.
Appointed

Christopher Moe

Chief Financial Officer
BLNE · Beeline Holdings, Inc.
Effective
2024-10-07
Filed
October 7, 2024, 7:59 PM ET
the Eastside Board of Directors appointed Christopher Moe, the Chief Financial Officer of Beeline, to serve as the Chief Financial Officer of Eastside.
Role change

Angela Walsh

Chief Financial Officer
DWTX · Dogwood Therapeutics, Inc.
Effective
2024-10-07
Filed
October 7, 2024, 7:59 PM ET
promoted Angela Walsh from her prior role of Senior Vice President of Finance to the Company’s Chief Financial Officer, effective immediately upon the Closing on October 7, 2024
Appointed

John Price

Chief Financial Officer
Assure Holdings Corp.
Effective
2024-10-01
Filed
October 7, 2024, 7:59 PM ET
On October 1, 2024, Assure Holdings Corp. (the “Company”) appointed John Price to act as the Company’s Chief Financial Officer beginning October 1, 2024.
Departed

Paul Webster

Interim Chief Financial Officer
Assure Holdings Corp.
Effective
2024-10-01
Successor
John Price
Filed
October 7, 2024, 7:59 PM ET
On September 13, 2024, Paul Webster, Interim Chief Financial Officer, tendered his resignation to the Company to be effective October 1, 2024.
Role change

Jatinder Dhaliwal

Chief Executive Officer
Virpax Pharmaceuticals, Inc.
Effective
2024-10-06
Filed
October 7, 2024, 7:59 PM ET
On October 6, 2024, the Board appointed Jatinder Dhaliwal, a member of the Board, to serve as Chief Executive Officer of the Company, effective immediately.
Departed

Vinay Shah

Chief Financial Officer
Virpax Pharmaceuticals, Inc.
Effective
2024-10-05
Filed
October 7, 2024, 7:59 PM ET
On October 5, 2024, Gerald Bruce, as Chief Executive Officer and member of the Board of Directors (the “Board”), and Vinay Shah, as Chief Financial Officer, notified the Company of their intention to resign for their respective positions, effective immediately.
Departed

Gerald Bruce

Chief Executive Officer
Virpax Pharmaceuticals, Inc.
Effective
2024-10-05
Successor
Jatinder Dhaliwal
Filed
October 7, 2024, 7:59 PM ET
On October 5, 2024, Gerald Bruce, as Chief Executive Officer and member of the Board of Directors (the “Board”), and Vinay Shah, as Chief Financial Officer, notified the Company of their intention to resign for their respective positions, effective immediately.
Appointed

Michael Arthur

Chief Financial Officer
Inspirato Inc
Effective
2024-11-08
Filed
October 4, 2024, 7:59 PM ET
the Compensation Committee of the Board of Directors of the Company approved the appointment of Michael Arthur as Chief Financial Officer, effective as of November 8, 2024.
Departed

Robert Kaiden

Chief Financial Officer
Inspirato Inc
Effective
2024-11-08
Successor
Michael Arthur
Filed
October 4, 2024, 7:59 PM ET
Robert Kaiden will be resigning from his position as Chief Financial Officer at Inspirato Incorporated (the “Company”) effective as of November 8, 2024.
Appointed

John Townsend

Executive Vice President, Chief Financial Officer
RBBN · Ribbon Communications Inc.
Filed
October 4, 2024, 7:59 PM ET
On October 3, 2024, Ribbon Communications Inc. (the “Company”) announced the appointment of John Townsend as Executive Vice President, Chief Financial Officer of the Company, effective upon the earlier of the filing of the Company’s Form 10-Q for the quarter ended September 30, 2024 and November 1, 2024 (the “Effective Date”).
Departed

Miguel Lopez

Executive Vice President, Chief Financial Officer
RBBN · Ribbon Communications Inc.
Successor
John Townsend
Filed
October 4, 2024, 7:59 PM ET
As previously reported, Miguel Lopez, the Company’s current Executive Vice President, Chief Financial Officer, is retiring from the Company following the filing of the Company’s Form 10-Q for the quarter ended September 30, 2024.
Departed

Robert Jornayvaz III

Chief Executive Officer
IPI · Intrepid Potash, Inc.
Effective
2024-09-30
Filed
October 4, 2024, 7:59 PM ET
Effective September 30, 2024, Mr. Jornayvaz resigned from all positions with the Company and its subsidiaries and affiliates, including as the Chief Executive Officer and as a member of its Board of Directors (the “Board”).
Appointed (interim)

Joseph La Rosa

Interim Chief Financial Officer
LRHC · La Rosa Holdings Corp.
Effective
2024-10-01
Filed
October 4, 2024, 7:59 PM ET
Joseph La Rosa, the Chief Executive Officer and the Chairman of the Board of Directors (the “Board”), was appointed to also temporarily serve as the interim Chief Financial Officer of the Company while the Company conducts its search for a successor, effective as of October 1, 2024.
Departed

Kent Metzroth

Executive Vice President and Chief Financial Officer
LRHC · La Rosa Holdings Corp.
Effective
2024-09-30
Successor
Joseph La Rosa
Filed
October 4, 2024, 7:59 PM ET
Effective as of September 30, 2024, Kent Metzroth resigned from his position as Executive Vice President and Chief Financial Officer of the Company.
Departed

David A. King

Chief Executive Officer
ARTW · ARTS WAY MANUFACTURING CO INC
Effective
2024-10-01
Successor
Marc H. McConnell
Filed
October 4, 2024, 7:59 PM ET
On October 1, 2024, Art’s-Way Manufacturing Co., Inc. (the “Company”) and David A. King, the Company’s Chief Executive Officer since 2020, mutually agreed to terminate Mr. King’s employment agreement and employment with the Company effective immediately.
Appointed

Marc H. McConnell

President and Chief Executive Officer
ARTW · ARTS WAY MANUFACTURING CO INC
Effective
2024-10-04
Filed
October 4, 2024, 7:59 PM ET
On October 4, 2024, the Company’s Board of Directors appointed Marc H. McConnell, Chairman of the Company’s Board of Directors, to serve as President and Chief Executive Officer, effective immediately.
Appointed (interim)

Ari Olgun

Interim Chief Financial Officer
Loop Media, Inc.
Effective
2024-10-01
Filed
October 4, 2024, 7:59 PM ET
Effective October 1, 2024, Mr. Ari Olgun (“ Mr. Olgun ”) was appointed to serve as Interim Chief Financial Officer (“ Interim CFO ”) to fill the vacancy created by Mr. Watanabe’s departure from the Company.
Departed (interim)

Neil Watanabe

Chief Financial Officer
Loop Media, Inc.
Effective
2024-09-30
Successor
Ari Olgun
Filed
October 4, 2024, 7:59 PM ET
Effective as of September 30, 2024 (the “ Departure Effective Date ”), following the expiration of his employment agreement dated September 30, 2021, Mr. Neil Watanabe (“ Mr. Watanabe ”), the Company’s Chief Financial Officer (“ CFO ”), departed from his role as CFO of the Company after three years of service to pursue other opportunities outside of the Company.
Appointed

Vincent Paul (VP) Berger II

Executive Vice President and Chief Financial Officer
HNI · HNI CORP
Effective
2024-12-29
Filed
October 3, 2024, 7:59 PM ET
On October 1, 2024, the Board of Directors appointed Vincent Paul (VP) Berger II as Executive Vice President (“EVP”) and CFO, effective December 29, 2024, to succeed Mr. Bridges as the Corporation’s principal financial officer.
Departed

Marshall H. Bridges

Senior Vice President and Chief Financial Officer
HNI · HNI CORP
Effective
2024-12-28
Successor
Vincent Paul (VP) Berger II
Filed
October 3, 2024, 7:59 PM ET
On September 27, 2024, Marshall H. Bridges notified HNI Corporation (the “Corporation” or “HNI”) of his decision to retire as Senior Vice President (“SVP”) and Chief Financial Officer (“CFO”), effective December 28, 2024.
Departed

Brian Scott

Executive Vice President and Chief Financial Officer
JACK · JACK IN THE BOX INC
Effective
2024-11-20
Successor
Dawn Hooper
Filed
October 3, 2024, 7:59 PM ET
On September 30, 2024, Brian Scott notified the Company of his intention to resign from his position as the Company’s Executive Vice President and Chief Financial Officer, effective November 20, 2024.
Appointed (interim)

Dawn Hooper

Interim Chief Financial Officer
JACK · JACK IN THE BOX INC
Effective
2024-11-20
Filed
October 3, 2024, 7:59 PM ET
Dawn Hooper, the Company’s Senior Vice President, Controller will serve as the Company’s interim principal financial officer effective November 1, 2024, and as Interim Chief Financial Officer effective upon Mr. Scott’s departure until such time that a successor Chief Financial Officer is appointed.
Appointed

Brian Scott

Chief Financial Officer and Chief Operating Officer
AMN · AMN HEALTHCARE SERVICES INC
Effective
2024-11-21
Filed
October 3, 2024, 7:59 PM ET
On October 3, 2024, AMN Healthcare Services, Inc. (“AMN” or the “Company”) announced that Brian Scott will join AMN as its Chief Financial Officer and Chief Operating Officer (“CFO/COO”) reporting to Cary Grace, AMN’s President and Chief Executive Officer.
Departed

Jeffrey Knudson

Chief Financial Officer
AMN · AMN HEALTHCARE SERVICES INC
Effective
2024-11-08
Successor
Brian Scott
Filed
October 3, 2024, 7:59 PM ET
the departure of Jeffrey Knudson from his role as the Company’s CFO, effective November 8, 2024, to pursue an opportunity with a private company outside of the healthcare industry.
Appointed

Travis B. Johnson

Chief Financial Officer and Chief Accounting Officer
AMTM · Amentum Holdings, Inc.
Effective
2024-09-27
Filed
October 3, 2024, 7:59 PM ET
the following individuals were elected as officers of the Company in each case until their successors are chosen and qualify in their stead or until their earlier death, resignation or removal: ● Jill Bruning, Chief Technology Officer ● Steven J. Demetriou, Executive Chair ● John Heller, Chief Executive Officer ● Travis B. Johnson, Chief Financial Officer and Chief Accounting Officer ● Sean Mullen, Chief Growth Officer ● Stuart I. Young, Chief Legal Officer
Appointed

John Heller

Chief Executive Officer
AMTM · Amentum Holdings, Inc.
Effective
2024-09-27
Filed
October 3, 2024, 7:59 PM ET
the following individuals were elected as officers of the Company in each case until their successors are chosen and qualify in their stead or until their earlier death, resignation or removal: ● Jill Bruning, Chief Technology Officer ● Steven J. Demetriou, Executive Chair ● John Heller, Chief Executive Officer ● Travis B. Johnson, Chief Financial Officer and Chief Accounting Officer ● Sean Mullen, Chief Growth Officer ● Stuart I. Young, Chief Legal Officer
Departed

David I. Bruce

Chief Executive Officer
IRIX · IRIDEX CORP
Effective
2024-10-01
Successor
Patrick Mercer
Filed
October 3, 2024, 7:59 PM ET
replacing David I. Bruce in such roles
Appointed

Patrick Mercer

Chief Executive Officer
IRIX · IRIDEX CORP
Effective
2024-10-01
Filed
October 3, 2024, 7:59 PM ET
On October 1, 2024, the board of directors (the “Board”) of IRIDEX Corporation (the “Company”) appointed Patrick Mercer as its Chief Executive Officer and designated Mr. Mercer as the Company’s principal executive officer for purposes of the rules and regulations of the Securities and Exchange Commission (the “SEC”), effective as of such date, replacing David I. Bruce in such roles.
Departed

Sheamus Toal

Chief Operating Officer and Chief Financial Officer
PLCE · Childrens Place, Inc.
Effective
2024-12-13
Filed
October 3, 2024, 7:59 PM ET
On October 3, 2024, the Company also announced that Sheamus Toal will be leaving his positions as Chief Operating Officer and Chief Financial Officer, effective December 13, 2024.
Appointed

Mary Beth Harler, M.D.

Chief Executive Officer and Director
IGM Biosciences, Inc.
Effective
2024-09-30
Filed
October 3, 2024, 7:59 PM ET
Mary Beth Harler, M.D. has been appointed as the Company’s Chief Executive Officer, effective as of the Effective Date, and as a member of the Board (initial term ending at the annual stockholder meeting in 2025), effective as of October 1, 2024.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.